P

Personalis
D

PSNL

18.100
USD
1.32
(7.81%)
قبل الجلسة·16.750USD-1.350(-7.46%)
حجم التداول
313,480
الربح لكل سهم
-1
العائد الربحي
-
P/E
-17
حجم السوق
1,945,893,668
أصول ذات صلة المقالات
المزيد

العنوان: Personalis

القطاع: الرعاية الصحية
الصناعة: Diagnostics & Research
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.